Canaan Partners X LLC, 10% Owner at Protagonist Therapeutics, Inc (PTGX), sold 329,494 shares at $6.46 ($2.1M) on 2018-05-16, disclosed to the SEC on 2018-05-16.
Open-market sale of $2.1M PTGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.37 | 77,591 | $494K | 23.3% |
| 2 | $6.37 | 77,591 | $494K | 23.3% |
| 3 | $6.48 | 57,715 | $374K | 17.7% |
| 4 | $6.48 | 57,715 | $374K | 17.7% |
| 5 | $6.46 | 29,441 | $190K | 9.0% |
| 6 | $6.46 | 29,441 |
| $190K |
| 9.0% |
| Total | $6.42 avg | 329,494 | $2.1M | 100% |
| Filing → |
| PTGX | SELL | 2018-03-19 | $837K | — | Filing → |
| PTGX | SELL | 2018-03-15 | $514K | — | Filing → |